ANALOGUES OF VDAC1-DERlVED PEPTIDES

Research output: Patent

Abstract

The present invention relates to peptides comprising analogues of VDAC1-derived peptides having improved pharmacokinetic characteristics compared to the native parent peptides, which are effective in impairing cell energy production, in inducing apoptosis and cell death, particularly of cancerous cells, in eliminating cancer stem cells and in reducing symptoms associated with fat accumulation in liver cells particularly with nonalcoholic fatty liver disease (NAFLD) and symptoms associated thereto

Original languageEnglish
Patent numberUS2018134760
IPCA61P 35/ 02 A I
Priority date11/01/18
StatePublished - 17 May 2018

Fingerprint

Dive into the research topics of 'ANALOGUES OF VDAC1-DERlVED PEPTIDES'. Together they form a unique fingerprint.

Cite this